Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novartis
Nkarta, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Beijing Biotech
Calibr, a division of Scripps Research
University of Washington
Alliance for Clinical Trials in Oncology
AstraZeneca
British Columbia Cancer Agency
Eastern Cooperative Oncology Group
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Vironexis Biotherapeutics Inc.
Memorial Sloan Kettering Cancer Center
Novartis
City of Hope Medical Center
Galapagos NV
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Incyte Corporation
Gilead Sciences
Beijing GoBroad Hospital
Beijing GoBroad Hospital
Autolus Limited
Fred Hutchinson Cancer Center
Autolus Limited
Bristol-Myers Squibb
Beijing GoBroad Hospital
Arkansas Children's Hospital Research Institute
Zhejiang University
Children's Oncology Group
Children's Oncology Group
Children's Hospital of Philadelphia
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS
Schrödinger, Inc.
St. Jude Children's Research Hospital
University of Washington
OHSU Knight Cancer Institute
Imugene Limited
City of Hope Medical Center
City of Hope Medical Center